Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 3 Clinical Trial: D-methionine to Reduce Noise-Induced Hearing Loss (NIHL)

NCT02903355 is registered in ClinicalTrials.gov with Southern Illinois University as lead sponsor.

NCT NCT02903355
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02903355 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 3 Clinical Trial: D-methionine to Reduce Noise-Induced Hearing Loss (NIHL)
Lead sponsor
Southern Illinois University
Phase
Phase 3
Overall status
Terminated
Start date
September 30, 2013
Completion date
December 31, 2017
Enrollment
351 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

noise-induced hearing loss